Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

Published

Journal Article (Review)

Diabetes mellitus and obesity have become increasingly prevalent problems worldwide. Unfortunately, with traditionally prescribed glucose-lowering medications most individuals with diagnosed diabetes do not achieve and maintain adequate glycemic control over time; it may be even more challenging to lower blood glucose to an appropriate level without inducing a significant associated weight gain. Exenatide and rimonabant are recently developed agents that have demonstrated benefit in both glucose lowering and reduction of body weight. These medications may well prove to be attractive alternatives or additions to our more established diabetes therapies; however, these drugs have a side-effect profile that may limit their applicability to certain populations.

Full Text

Duke Authors

Cited Authors

  • Green, JB; Feinglos, MN

Published Date

  • October 2007

Published In

Volume / Issue

  • 7 / 5

Start / End Page

  • 369 - 375

PubMed ID

  • 18173970

Pubmed Central ID

  • 18173970

International Standard Serial Number (ISSN)

  • 1534-4827

Digital Object Identifier (DOI)

  • 10.1007/s11892-007-0060-0

Language

  • eng

Conference Location

  • United States